Spinal antinociceptive effects of cyclooxygenase inhibition during inflammation: Involvement of prostaglandins and endocannabinoids-Reference-Cited by-同舟云学术

Spinal antinociceptive effects of cyclooxygenase inhibition during inflammation: Involvement of prostaglandins and endocannabinoids

Published:2010-01 Issue:1 Volume:148 Page:26-35
ISSN:0304-3959
Container-title:Pain
language:en
Short-container-title:

Author:

Telleria-Diaz Alejandro,Schmidt Martin,Kreusch Stefan,Neubert Anne-Kathrin,Schache Florian,Vazquez Enrique,Vanegas Horacio,Schaible Hans-Georg,Ebersberger Andrea

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Anesthesiology and Pain Medicine,Neurology (clinical),Neurology

Reference65 articles.

1. Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors.;Agarwal;Nat Neurosci,2007

2. PGE(2) selectively blocks inhibitory glycinergic neurotransmission onto rat superficial dorsal horn neurons.;Ahmadi;Nat Neurosci,2002

3. Direct activation of rat spinal dorsal horn neurons by prostaglandin E2.;Baba;J Neurosci,2001

4. Changes in the effect of spinal prostaglandin E2 during inflammation: prostaglandin E (EP1-EP4) receptors in spinal nociceptive processing of input from the normal or inflamed knee joint.;Bar;J Neurosci,2004

5. Lipid signals in pain control.;Bazan;Nature,2002

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Wwl70-induced ABHD6 inhibition attenuates memory deficits and pathological phenotypes in APPswe/PS1dE9 mice;Pharmacological Research;2023-08

2. The Clinical Pharmacology and Therapeutic Evaluation of Non-Steroidal Anti-Inflammatory Drugs in Adult Horses;Animals;2023-05-10

3. Potential role of the hydroxyl carboxylic acid receptor type 2 (HCAR2) in microglia pathophysiology: A possible cross-talk with C-X-C chemokine receptor 1 (CXCR1);Neuropharmacology;2023-05

4. Spinal pain processing in arthritis: Neuron and glia (inter)actions;Journal of Neurochemistry;2023-01-05

5. Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities;Progress in Lipid Research;2023-01